Kimishige Ishizaka (1925–2018)

Hirohisa SaitoEmail the author Hirohisa Saito

National Research Institute for Child Health & Development, 2-10-1 Okura, Setagaya-ku, Tokyo 157-8535, Japan

Open Access

DOI: https://doi.org/10.1016/j.alit.2018.07.007

Article Info

• Abstract

• Full Text

• Images
• References

Article Outline

1. Conflict of interest
2. References

Dr. Kimishige Ishizaka (Fig. 1) passed peacefully away from heart failure at dawn of July 6, 2018 in Yamagata, Japan. Dr. Kimishige Ishizaka and Dr. Teruko Ishizaka (the Ishizakas; partners in marriage and in research) were best known for their discovery of immunoglobulin E (IgE) in 1966.1

Fig. 1

Kimishige Ishizaka, December 3, 1925–July 6, 2018. A photo was taken at the reception celebrating the 50th Anniversary of IgE Discovery held at the 65th Annual Meeting of Japanese Society of Allergology, on June 19, 2016.

The prostaglandin D2 receptor 2 pathway in asthma: a key player in airway inflammation

• Review
• Open Access

• Christian Domingo,
• Oscar Palomares,
• David A. Sandham,
• Veit J. Erpenbeck and
• Pablo AltmanEmail author

Respiratory Research201819:189

Abstract

Asthma is characterised by chronic airway inflammation, airway obstruction and hyper-responsiveness. The inflammatory cascade in asthma comprises a complex interplay of genetic factors, the airway epithelium, and dysregulation of the immune response.

Gut microbiota relationships to lung function and adult asthma phenotype: a pilot study

BMJ Open Respiratory Research 2018;5:e000324. doi: 10.1136/bmjresp-2018-000324

Lesa Begley1,  Siddharth Madapoosi1,  Kristopher Opron1,2,  Ogechukwu Ndum3,  Alan Baptist3,  Kelly Rysso1,  John R Erb-Downward1 and  Yvonne Jean Huang1
Abstract
Introduction Despite strong evidence that maturation patterns of the gut microbiome in early life influence the risk for childhood asthma, very little is known about gut microbiota patterns in adults with established asthma, and of greater interest relationships to phenotypic features that characterise asthma heterogeneity.

Seafood allergy: A comprehensive review of fish and shellfish allergens

Molecular Immunology

Volume 100, August 2018, Pages 28-57

Author links open overlay panelThimoRuethersabcd1Aya C.Takiabcd1Elecia B.JohnstonacdRoniNugrahaacdeThu T.K.LeacdTanjaKalicfThomas R.McLeangSandip D.KamathabcdAndreas L.Lopataabcd

https://doi.org/10.1016/j.molimm.2018.04.008

Highlights

•

Immunological cross-reactivity between fish and shellfish allergens has not been demonstrated conclusively.

A comparative analysis of errors in inhaler technique among COPD versus asthma patients

 International Journal of Chronic Obstructive Pulmonary Disease Volume 2018:13 Pages 2941—2947

Birsen Ocakli,¹ Ipek Ozmen,¹ Eylem Acartürk Tunçay,¹ Sinem Gungor,¹ Hilal Altinoz,¹ Nalan Adiguzel,¹Zafer Ali Sak,² Gokay Gungor,¹ Zuhal Karakurt,¹ Peri Arbak<sup>3

1</sup>University of Health Sciences, Sureyyapasa Chest Diseases and Thoracic Surgery Training and Research Hospital, Istanbul, Turkey; ²Department of Chest Diseases, Harran University, Faculty of Medicine, Sanliurfa, Turkey; ³Department of Chest Diseases, Duzce University, Faculty of Medicine, Duzce, Turkey

Purpose: This study was designed to evaluate errors in inhaler technique in COPD vs asthma patients and to investigate the association of poor inhaler technique with patient demographics and clinical variables.

An observational cohort study of the use of five-grass-pollen extract sublingual immunotherapy during the 2015 pollen season in France

• Research
• Open Access

• Patrick BlinEmail authorView ORCID ID profile,
• Pascal Demoly,
• Martine Drouet,
• Bruno Falissard,
• Séverine Lignot-Maleyran,
• Hélène Maizi,
• Simon Lorrain,
• Régis Lassalle,
• Cécile Droz-Perroteau,
• Nicholas Moore and
• Mathieu Molimard

Allergy, Asthma & Clinical Immunology201814:38

Abstract

Background

Allergic rhinitis affects around one quarter of the Western European population. Prophylactic allergen immunotherapy may be useful to reduce the risk of acute symptomatic attacks (hayfever). A five-grass pollen extract sublingual immunotherapy (5GPE-SLIT) has been developed for the treatment of allergic rhinitis to grass pollen.

Duration of Allergen Immunotherapy for Long-Term Efficacy in Allergic Rhinoconjunctivitis

Current Treatment Options in Allergy

September 2018, Volume 5, Issue 3, pp 275–290

• Martin Penagos 
• Aarif O. Eifan 
• Stephen R. Durham
• Guy W. Scadding

1. 1.

Open Access 

Specific Immunotherapy (L Cox, Section Editor)

First Online: 31 August 2018

Part of the following topical collections:

1. Topical Collection on Specific Immunotherapy

Abstract

Rationale

Subcutaneous and sublingual immunotherapy are effective for allergic rhinitis. An important question is whether allergen immunotherapy provides a sustained clinical effect after treatment cessation. In view of potential side effects, cost and the necessary patient commitment, long-term benefit is an important consideration for the recommendation of immunotherapy over standard pharmacotherapy.

The following new articles have just been published in Allergy, Asthma & Clinical Immunology

Allergy, Asthma & Clinical Immunology

The following new articles have just been published in Allergy, Asthma & Clinical Immunology REVIEW Anaphylaxis David Fischer, Timothy K. Vander Leek, Anne K. Ellis and Harold Kim Allergy, Asthma & Clinical Immunology 2018, 14:54 | Published on: 12 September 2018 Full Text | PDF